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Proteome Fishing: A Reverse Docking Study
A Proposal for the Research & Creative Experiences for Undergraduates Program, Summer 201 8

FACULTY RESEARCH MENTOR
Kendall G Byler, Department of Chemistry, MSB C223.

Phone: 256-479-1150

Email: kgb0011@uah.edu

PROJECT SUMMARY
The field of pharmacognosy has a long history of natural products discovery, providing lead structures to the pharmaceutical
industry for the development of new drug compounds. 924 of the 1010 FDA new chemical entities reported from 01/1981
to 06/2006 were directly isolated from natural products or were synthesized from natural products precursors and
pharmacophores; 490 of these were directly isolated from natural products. Working from the observation that natural
product structures avoid many of the toxicity and bioavailability issues associated with xenobitics, natural products offer an
ideal starting point for drug design and development. The overall goal of this research project is to identify natural product
structures that bind to protein targets known to be associated with disease states in humans through a reverse docking
experiment. In reverse docking[1], a large collection of protein crystal structures with known binding sites and established
biological function as drug targets are screened in silico for ligand-receptor affinity. The utility of reverse docking is twofold:
1) to probe for targets in cases where biological activity has been determined by assay but the specific target has not yet
been identified and 2) where secondary targets are identified, but additional in vitro or in vivo screening is lacking. The
Potential Drug Target Database (PDTD) reverse docking library[2] contains 1207 X-ray crystal structures, representing 841
known and potential drug targets, to which has been added several structures in emergent pathogens such as T. vaginalis
and C. auris.
In this work, the typical scenario of screening a large database of small molecules to one or a few protein targets is upended
and an in-house natural products library will be screened for similarity to known actives in the species represented across
the reverse docking library, but whose mode(s) of action are as yet unknown. The resulting small set of leads will then be
submitted for docking to the receptor library to elucidate possible modes of action. In addition, any secondary hits –
unexpectedly favorable ligand-receptor interactions - will highlight avenues to pursue in future screening efforts. This
project will introduce current methods in large-scale drug discovery initiatives and provide the student with valuable
experience in molecular docking and screening and in parallel computing.

STUDENT PREREQUISITES
The student should be familiar with organic chemical structures and functional groups: CH331 is a prerequisite. Familiarity
with file handling in the Unix enviroment will be necessary,as will some familiarity with Python scripting.

STUDENT DUTIES
ALABAMA SUPERCOMPUTING CENTER
The student will gain access to the Alabama Supercomputer Center’s Dense Memory Cluster in order to make use of the
computing power needed to screen such a large number of targets. The reverse docking library is already prepared for
use with the VINA/SMINA docking program and Python scripts have been written to manage the docking runs in parallel
on the compute nodes.

MOLECULAR DOCKING
An in-house data set of biologically active natural products structures will be screened for similarity to known actives in
the ChEMBL database, as well as privileged structure[3] screening. This reduced subset will then be submitted to the
DMC for docking across the reverse docking library. Top hits in this case identify targets within either pathogenic species
or in humans to suggest lead structures for biological screening.

MANUSCRIPT PREPARATION
The student is encouraged to assemble the results of this work in the form of a scientific journal article for publication.
Dr. Byler will assist the student in this effort and may include the results of previous and concurrent studies into the final
manuscript.

EXPECTED RESULTS
The ligand-receptor complexes identified in this project will be promoted to colleagues in the biological sciences for
validation by in vitro screenings and will form the basis for a drug discovery journal publication.

MENTOR SUPERVISION & INTERACTION
Dr. Byler will introduce key concepts in computational chemistry relevant to this research, such as homology modeling and
molecular docking, and familiarize the student with the software and hardware associated with each technique. Dr. Byler is
an expert in computational methods and routinely uses these methods[4] in the study of chemical systems in computational
drug discovery. Regular meetings will be held twice weekly with Dr. Byler; his office in MSB 223 is down the stairwell from
the MSB computer lab in MSB 317.
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